Diagnostika i sovershenstvovanie antibakterial'nogo lecheniya sinusita
- Авторлар: Nosulya E.V.1
-
Мекемелер:
- Шығарылым: № 1s (2011)
- Беттер: 40-43
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278779
- ID: 278779
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Аннотация
The article considers current indications for antibiotic therapy and characteristics of antibiotic therapy of sinusitis, in particular, the timing of the start and duration of treatment, recommendations for the rational choice of antibiotics. Combination drug of amoxicillin with β-lactamase inhibitor clavulanic acid is widely used in antibacterial therapy (ABT) of sinusitis. II and III generation cephalosporins also have high activity against the most probable causative agents of acute sinusitis. In case of intolerance to these medications, the use of modern macrolides is recommended, but possible limitations of this group of antimicrobial agents associated with the spread of resistant strains should be taking into account. Any recommendations on the duration of ABT for acute sinusitis are fairly conditional, because individual terms of regression of clinical manifestations of sinusitis, general condition of the patient, body temperature, and changes in the intensity of headaches, abnormal nasal discharge and nasal obstruction should be considered. The average duration of ABT for acute sinusitis is at least 7-10 days.
Негізгі сөздер
Толық мәтін
Әдебиет тізімі
- Страчунский Л.С., Каманин Е.И. Антибактериальная терапия инфекций в оториноларингологии // РМЖ, 1998. Т. 6. № 17.
- Крюков А.И., Туровский А.Б. Этиотропная терапия бактериального синусита // Consilium medicum, 2005. Т. 7. № 1.
- de Ferranti S.D., Ioannidis J.P., Lau J., et al. Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A metaanalysis. BMJ 1998; 5(317(7159)): 632-37.
- Williams J.W. Jr., Aguilar C., Cornell J., et al. Cochrane Database Syst Rev 2003; 2: CD000243.
- Дерюгина О.В., Чумаков Ф.И. Орбитальные и внутричерепные осложнения воспалительных заболеваний носа и околоносовых пазух у взрослых и детей. М., 2001.
- Пискунов С.З., Тарасов И.В., Медведкова И.Г. Лечебная тактика при риногенных орбитальных осложнениях // Российская ринология 1995. № 2. С. 48-9.
- Gay K., Baughman W., Miller Y. The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment. J Infect Dis 2000; 182(5): 1417-24.
- Козлов Р.С. Пневмококки: прошлое, настоящее, будущее. М., 2005. С. 41.
- Burke T., Villanueva C., Mariano H. Jr., et al. Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group. Clin Ther 1999; 217: 1664-77.
- Siegert R., Gehanno P., Nikolaidis P., et al. A comparison of the safety and efficacy of moxifloxacin and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. Sinusitis Study Group. Respir Med 2000; 94: 337-44.
- Pfaller M.A., Jones R.N. Gatifloxacin phase IV surveillance trial (TeqCES study) utilizing 5000 primary care physician practices: report of pathogens isolated and susceptibility patterns in community-acquired respiratory tract infections. Diagn Microbiol Infect Dis 2002; 44: 77-84.
Қосымша файлдар
